Alopecia News

Women who wear hijab are among the highest risk for developing traction alopecia, yet they are likely underrepresented in alopecia studies, according to a letter in Journal of the American Academy of Dermatology.

As we close out National Hair Loss Awareness Month, marked each year in August, Healio Dermatology has compiled the most read alopecia stories of 2023.

Pooled analysis of two clinical trials found patients with alopecia who did not respond to 2 mg of baricitinib had a significant improvement with a 4 mg dose.

Cryotherapy may lower disease relapse in patients with alopecia areata compared with intralesional corticosteroid injections or topical steroids, according to a study.

Efficacy and safety outcomes in adolescents treated with ritlecitinib for severe alopecia areata were consistent with adults in the same indication, according to a subgroup analysis of a phase 2b/3 trial.

In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including recent approvals and new treatments for alopecia areata.

In this edition, novel serum improves hair growth in androgenetic alopecia; cardiovascular disease linked to dermatological inflammatory diseases; sugary drinks may be associated with male pattern hair loss and more.

In a panel-led project, 23 experts created a comprehensive guide for the long-term management of inflammatory skin diseases in pediatric patients treated with methotrexate.

Pauci-follicular unit counts in alopecia biopsies can help to recognize and diagnose traction alopecia, according to a study.

Derma rollers have been around since the early 1900s and have been used to treat a variety of skin conditions from acne scars to fine lines and wrinkles.